| Airway Clearance with Expiratory Flow Accelerator Technology: Effectiveness of the “Free Aspire” Device in Patients with Severe COPD | Giorgia Patrizio, Michele D Andria, Francesco D Abrosca, Antonella Cabiaglia, Fabio Tanzi, Giancarlo Garuti, Antonello Nicolini | 209–215 |
| Factors Affecting Cost of Patients with Severe CommunityAcquired Pneumonia in Intensive Care Unit | Zuhal Karakurt, Emine Aksoy, Melike Cengiz, Özlem Çakın, Ayça Gümüş, Begüm Ergan, Aykut Çilli | 216–223 |
| Effect of Pulmonary Rehabilitation on the Value of the Inspiratory Capacity–to–Total Lung Capacity (IC/TLC) Ratio to Determine Response to Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease | Yelda Varol, Hülya Şahin, Berna Kömürcüoğlu, Ülkü Aktürk | 224–229 |
| National Control of Tuberculosis: Does Primary Health Care System Play a Crucial Role in the Fight Against Tuberculosis? | Tarkan Özdemir, Mustafa Hamidullah Türkkanı, Çiğdem Özdilekcan, İbrahim Halil Akkuş | 230–235 |
| Serum Albumin as a Biomarker of Pulmonary Sarcoidosis Chronicity | Safayeth Jabeen Isma, Hesham R. Omar, Nadera Sweiss, Mehdi Mirsaeidi | 236–240 |
| Work-Related Symptoms of Patients with Asthma: A Multicenter Study | Dilşad MUNGAN,İpek ÖZMEN,Fatma EVYAPAN,Füsun TOPÇU,Metin AKGÜN,Peri ARBAK,Yılmaz BÜLBÜL | 241–247 |
| Is Induced Sputum A Useful Noninvasive Tool in the Diagnosis of Pulmonary Sarcoidosis? | Ayşe BAHA,Fatma YILDIRIM,Moshe STARK,Ayşe KALKANCI,Elizabeth FİREMAN,Nurdan KÖKTÜRK | 248–252 |
| What will Happen in the World of COPD 2030? | Richard E. K. RUSSELL,Mona BAFADHEL | 253–257 |
| Benign Endobronchial Inflammatory Polyp with Cystic Degeneration: A Case Report | Ashok KUWAL,Manish ADVANİ,Devendra Raj MATHUR | 258–261 |
| Tooth Aspiration in a Patient with Traumatic Brain Injury | Ioannis PANTAZOPOULOS,Stelios KOKKORİS,Christina ROUTSİ | 262–264 |
| Importance of Reading and Publishing Case Reports | Öner DİKENSOY | 265–266 |
|